These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 34268768)
1. Metformin suppresses self-renewal and stemness of cancer stem cell models derived from pluripotent stem cells. Zahra MH; Afify SM; Hassan G; Nawara HM; Kumon K; Seno A; Seno M Cell Biochem Funct; 2021 Oct; 39(7):896-907. PubMed ID: 34268768 [TBL] [Abstract][Full Text] [Related]
2. Metformin Suppresses Self-Renewal Ability and Tumorigenicity of Osteosarcoma Stem Cells via Reactive Oxygen Species-Mediated Apoptosis and Autophagy. Zhao B; Luo J; Wang Y; Zhou L; Che J; Wang F; Peng S; Zhang G; Shang P Oxid Med Cell Longev; 2019; 2019():9290728. PubMed ID: 31827709 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity. Gatti M; Solari A; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Würth R; Corsaro A; Bajetto A; Ratto A; Ferrari A; Daga A; Barbieri F; Florio T Exp Cell Res; 2018 Feb; 363(1):48-64. PubMed ID: 29305964 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors. Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842 [TBL] [Abstract][Full Text] [Related]
6. Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell. Nishi M; Akutsu H; Kudoh A; Kimura H; Yamamoto N; Umezawa A; Lee SW; Ryo A Oncotarget; 2014 Sep; 5(18):8665-80. PubMed ID: 25228591 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells. Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286 [TBL] [Abstract][Full Text] [Related]
8. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells. Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066 [TBL] [Abstract][Full Text] [Related]
9. New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate. Cui J; Hollmén M; Li L; Chen Y; Proulx ST; Reker D; Schneider G; Detmar M Oncotarget; 2017 Jan; 8(1):1007-1022. PubMed ID: 27894093 [TBL] [Abstract][Full Text] [Related]
10. A novel model of liver cancer stem cells developed from induced pluripotent stem cells. Afify SM; Sanchez Calle A; Hassan G; Kumon K; Nawara HM; Zahra MH; Mansour HM; Khayrani AC; Alam MJ; Du J; Seno A; Iwasaki Y; Seno M Br J Cancer; 2020 Apr; 122(9):1378-1390. PubMed ID: 32203212 [TBL] [Abstract][Full Text] [Related]
11. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway. Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993 [TBL] [Abstract][Full Text] [Related]
12. A model of cancer stem cells derived from mouse induced pluripotent stem cells. Chen L; Kasai T; Li Y; Sugii Y; Jin G; Okada M; Vaidyanath A; Mizutani A; Satoh A; Kudoh T; Hendrix MJ; Salomon DS; Fu L; Seno M PLoS One; 2012; 7(4):e33544. PubMed ID: 22511923 [TBL] [Abstract][Full Text] [Related]
13. Concomitant targeting of multiple key transcription factors effectively disrupts cancer stem cells enriched in side population of human pancreatic cancer cells. Wang X; Liu Q; Hou B; Zhang W; Yan M; Jia H; Li H; Yan D; Zheng F; Ding W; Yi C; Hai Wang PLoS One; 2013; 8(9):e73942. PubMed ID: 24040121 [TBL] [Abstract][Full Text] [Related]
14. Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs. Ning X; Du Y; Ben Q; Huang L; He X; Gong Y; Gao J; Wu H; Man X; Jin J; Xu M; Li Z Cell Cycle; 2016; 15(3):403-12. PubMed ID: 26709750 [TBL] [Abstract][Full Text] [Related]
15. [Metformin inhibits self-renewal of colorectal cancer stem cells by inhibiting mitochondrial oxidative phosphorylation]. Yan C; Liu S; Song Q; Hu Y Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1279-1286. PubMed ID: 37712263 [TBL] [Abstract][Full Text] [Related]
16. Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma. Kojima H; Okumura T; Yamaguchi T; Miwa T; Shimada Y; Nagata T Int J Oncol; 2017 Jul; 51(1):49-62. PubMed ID: 28534989 [TBL] [Abstract][Full Text] [Related]
17. Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies. Lonardo E; Cioffi M; Sancho P; Crusz S; Heeschen C J Vis Exp; 2015 Jun; (100):e52801. PubMed ID: 26132091 [TBL] [Abstract][Full Text] [Related]
18. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression. Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717 [TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro. Chen X; Hu C; Zhang W; Shen Y; Wang J; Hu F; Yu P Tumour Biol; 2015 Dec; 36(12):9873-83. PubMed ID: 26164004 [TBL] [Abstract][Full Text] [Related]
20. Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells. Lee H; Kim JW; Kim DK; Choi DK; Lee S; Yu JH; Kwon OB; Lee J; Lee DS; Kim JH; Min SH Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]